Clinical Trial Update: A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating tolerance, pharmacokinetics and efficacy of TQ-A3334 tablets for non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TQ-A3334 (TQ-A3334)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED